Birkenstock Holding reports Q2 results just as the borrow market hits its tightest point of the year — a collision of fundamental disappointment and peak short positioning that sets up a charged backdrop heading into the post-earnings session.
The Q2 print told a mixed story. Sales of $724M came in fractionally ahead of the $723.9M estimate, but adjusted EPS of $0.59 missed the $0.70 consensus by a wide margin. Management reaffirmed full-year guidance — adj. EPS of $2.22–$2.40 versus the $2.39 estimate, and sales of $2.76B–$2.81B above the $2.74B estimate — but the margin miss was the headline. Tariffs, foreign exchange headwinds, and Middle East-related disruption all visibly bit into profitability, leaving investors with a revenue beat that felt hollow given the EPS shortfall. The stock dropped 3.1% on May 12 and is now down 7.2% year-to-date at $37.95, even after clawing back 1.4% over the week.
The lending market entered results week at maximum tightness. Availability dropped to zero — every share in the lending pool is currently lent out, matching the 52-week maximum and holding there for two consecutive days. That is the clearest measure of how stretched the short-side demand for BIRK has become. Short interest runs at 5.8% of free float, with roughly 10.7 million shares short — a level that has actually eased slightly over the week (down about 1.9%) and the month (down 3.2%), suggesting shorts trimmed modestly ahead of the print rather than piling in further. Cost to borrow has climbed 10% over the week to 1.13% and 21% over the past month, a gradual creep that reflects sustained demand pressure rather than an acute squeeze. With availability at zero and borrowing costs drifting higher, any new short would face a constrained entry. The ORTEX short score of 73.3 reinforces the picture — firmly elevated, placing BIRK in the bottom few percentiles of the universe on both the utilization and DTC factor ranks.
Options positioning, by contrast, has become less defensive than the fundamentals might warrant. The put/call ratio has eased to 0.90, running below its 20-day average of 0.97 and slightly on the bullish side of neutral — a modest 0.7 standard deviations below the mean. That reading has been drifting lower since late April, when the PCR sat above 1.0. Whether that reflects call buying into an expected bounce, or simply put decay post-earnings, is the interpretive question. The 52-week range on the PCR is wide (0.44 to 5.54), so the current level is far from extreme in either direction.
The Street remains broadly constructive but has been quietly trimming targets. Piper Sandler reiterated Overweight on April 27 but cut its target from $60 to $55. Stifel maintained Buy on April 22 while lowering to $56. A Seaport Global upgrade to Buy on April 14 with a $52 target added a fresh bull, yet the mean price target of $46.93 implies roughly 24% upside to current prices — a gap that looks even wider now given the post-earnings dip to $37.95. Bulls point to Americas and Asia-Pacific growth momentum, the brand's pricing power, and a vertically integrated manufacturing model. Bears flag tariff headwinds, capacity constraints, and fashion-cycle risk. The EV/EBITDA multiple has contracted about 3.7% over 30 days to 9.3x, while PE has compressed to 14.8x — multiples that look undemanding if the margin story stabilises, but which offer limited support if the EPS guide gets revised lower. The analyst recommendation differential ranks in the 94th percentile, meaning the Street is more uniformly positive on BIRK relative to peers — a high bar that can amplify disappointment.
On ownership, the picture is dominated by L Catterton's 54% stake, which has been trimmed by 15.3 million shares in the most recent filing. That reduction is the most material change in the cap table and is worth monitoring as a supply overhang. T. Rowe Price added 1.3 million shares in Q1, and several smaller managers built positions, providing a partial counterweight. Insider activity in late April was routine — a round of director awards followed by small same-day sales at $37.50, all at significance level 1 and far too modest in scale to be a signal.
The next earnings call is confirmed for May 15. The only prior reaction data available showed a muted 0.5% drop on the day after the February print, followed by a 1.1% five-day gain — a small sample with limited predictive weight. What to watch heading into the call is whether management provides any clarity on the tariff drag timeline and whether the EPS guide range tightens; with borrow fully consumed and shorts already trimming, the setup is less about fresh positioning and more about whether the margin narrative stabilises.
See the live data behind this article on ORTEX.
Open BIRK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
